Related Experiment Video
Updated: Jun 24, 2026
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
IFCC-HbA1c May Be More Useful than NGSP-HbA1c in the Comparison between HbA1c Values in Variant Hemoglobin with a
Masafumi Koga1, Shinya Inada2, Kei Yoshino3
1Department of Internal Medicine, Hakuhokai Central Hospital, Japan m-koga@kawanishi-city-hospital.com.
HbA1c values in variant hemoglobin with a mutation on α chain and β chain are assumed to be different because the α chain and β chain of the globin gene have two and one gene(s), respectively. We examined whether the differentiation between HbA1c values in variant hemoglobin with a mutation on α chain (C1α) and β chain (C1β) is possible. Three patients with C1α and 9 patients with C1β were included. HbA1c was measured by standard mode high-performance liquid chromatography (HPLC) (HPLC-HbA1c) and immunoassay (IA: IA-HbA1c). Glycated albumin (GA) was determined, and each ratio was compared. HbA1c is expressed in National Glycohemoglobin Standardization Program (NGSP) units (A1C) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) units (iA1c). Both the HPLC-A1C/IA-A1C ratio and the HPLC-iA1c/IA-iA1c ratio in C1α were significantly lower than those in C1β. Although there were no significant differences between the GA/HPLC-A1C ratios in both groups, the GA/HPLC-iA1c ratio in C1α was significantly higher than those in C1β. If the cutoff values for the HPLC/IA-iA1c ratio and GA/HPLC-iA1c ratio were set at 65% and 5.3, respectively, both sensitivity and specificity were 100%. Differentiation between C1α and C1β might be possible by using the HPLC-iA1c/IA-iA1c ratio or GA/HPLC-iA1c ratio.
HbA1c values in variant hemoglobin with a mutation on α chain and β chain are assumed to be different because the α chain and β chain of the globin gene have two and one gene(s), respectively. We examined whether the differentiation between HbA1c values in variant hemoglobin with a mutation on α chain (C1α) and β chain (C1β) is possible. Three patients with C1α and 9 patients with C1β were included. HbA1c was measured by standard mode high-performance liquid chromatography (HPLC) (HPLC-HbA1c) and immunoassay (IA: IA-HbA1c). Glycated albumin (GA) was determined, and each ratio was compared. HbA1c is expressed in National Glycohemoglobin Standardization Program (NGSP) units (A1C) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) units (iA1c). Both the HPLC-A1C/IA-A1C ratio and the HPLC-iA1c/IA-iA1c ratio in C1α were significantly lower than those in C1β. Although there were no significant differences between the GA/HPLC-A1C ratios in both groups, the GA/HPLC-iA1c ratio in C1α was significantly higher than those in C1β. If the cutoff values for the HPLC/IA-iA1c ratio and GA/HPLC-iA1c ratio were set at 65% and 5.3, respectively, both sensitivity and specificity were 100%. Differentiation between C1α and C1β might be possible by using the HPLC-iA1c/IA-iA1c ratio or GA/HPLC-iA1c ratio.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
